Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation

Audiology and Neurotology

Volumn 13, Issue 2, 2008, Pages 86-96

  James, David P ^a   Eastwood, Hayden ^a   Richardson, Rachael T ^a,b   O'Leary, Stephen J ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BIONIC EAR INSTITUTE   (Australia)

Author keywords

Cochlear implantation; Dexamethasone; Guinea pig; Hearing loss; Hearing thresholds; Round window membrane

Indexed keywords

CARBOXYMETHYLCELLULOSE; DEXAMETHASONE; HYALURONIC ACID; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY STIMULATION; BRAIN STEM RESPONSE; COCHLEA FENESTRA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; ELECTRODE; FOREIGN BODY REACTION; GUINEA PIG; HEARING; HISTOPATHOLOGY; IMPLANTATION; NONHUMAN; OTITIS; PRIORITY JOURNAL; PURE TONE AUDIOMETRY; SURGICAL TECHNIQUE;

ADRENAL CORTEX HORMONES; ANIMALS; AUDIOMETRY, PURE-TONE; COCHLEAR IMPLANTATION; DEXAMETHASONE; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HEARING; POSTOPERATIVE COMPLICATIONS; ROUND WINDOW, EAR;

EID: 38949125199     PISSN: 14203030     EISSN: 14219700     Source Type: Journal    
DOI: 10.1159/000111780     Document Type: Article

References (43)

1. Adunka O, Roush P, Grose J, Macpherson C, Buchman CA: Monitoring of cochlear function during cochlear implantation. Laryngoscope 2006;116:1017-1020.
2. Chandrasekhar SS, Rubinstein RY, Kwartler JA, Gatz M, Connelly PE, Huang E, Baredes S: Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000;122:521-528.
3. Choi CH, Oghalai JS: Predicting the effect of post-implant cochlear fibrosis on residual hearing. Hear Res 2005;205:193-200.
4. De Ceulaer G, Johnson S, Yperman M, Daemers K, Offeciers FE, O'Donoghue GM, Govaerts PJ: Long-term evaluation of the effect of intracochlear steroid deposition on electrode impedance in cochlear implant patients. Otol Neurotol 2003;24:769-774.
5. Eshraghi AA: Prevention of cochlear implant electrode damage. Curr Opin Otolaryngol Head Neck Surg 2006;14:323-328.
6. Eshraghi AA, He J, Mou CH, Polak M, Zine A, Bonny C, Balkany TJ, Van De Water TR: DJNKI-1 treatment prevents the progression of hearing loss in a model of cochlear implantation trauma. Otol Neurotol 2006;27:504-511.
7. Eshraghi AA, Polak M, He J, Telischi FF, Balkany TJ, Van De Water TR: Pattern of hearing loss in a rat model of cochlear implantation trauma. Otol Neurotol 2005;26:442-447.
8. Eshraghi AA, Van de Water TR: Cochlear implantation trauma and noise-induced hearing loss: apoptosis and therapeutic strategies. Anat Rec A Discov Mol Cell Evol Biol 2006;288:473-481.
9. Eshraghi AA, Wang J, Adil E, He J, Zine A, Bublik M, Bonny C, Puel JL, Balkany TJ, Van De Water TR: Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity. Hear Res 2007;226:168-177.
10. Gantz BJ, Turner C, Gfeller KE: Acoustic plus electric speech processing: preliminary results of a multicenter clinical trial of the Iowa/Nucleus Hybrid implant. Audiol Neurootol 2006;11(suppl 1):63-68.
11. Gantz BJ, Turner C, Gfeller KE, Lowder MW: Preservation of hearing in cochlear implant surgery: advantages of combined electrical and acoustical speech processing. Laryngoscope 2005;115:796-802.
12. Gianoli GJ, Li JC: Transtympanic steroids for treatment of sudden hearing loss. Otolaryngol Head Neck Surg 2001;125:142-146.
13. Gouveris H, Selivanova O, Mann W: Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol 2005;262:131-134.
14. Gstoettner W, Kiefer J, Baumgartner WD, Pok S, Peters S, Adunka O: Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngol 2004;124:348-352.
15. Gstoettner WK, Helbig S, Maier N, Kiefer J, Radeloff A, Adunka OF: Ipsilateral electric acoustic stimulation of the auditory system: results of long-term hearing preservation. Audiol Neurootol 2006;11(suppl 1):49-56.
16. Gstoettner W, Pok SM, Peters S, Kiefer J, Adunka O: Cochlear implantation with preservation of residual deep frequency hearing. HNO 2005;53:784-790.
17. Hargunani CA, Kempton JB, Degagne JM, Trune DR: Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006;27:564-569.
18. Ho HG, Lin HC, Shu MT, Yang CC, Tsai HT: Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment. Laryngoscope 2004;114:1184-1189.
19. Hoffer ME, Allen K, Kopke RD, Weisskopf P, Gottshall K, Wester D: Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology, and function. Laryngoscope 2001;111:1343-1357.
20. Hu BH, Henderson D, Nicotera TM: Extremely rapid induction of outer hair cell apoptosis in the chinchilla cochlea following exposure to impulse noise. Hear Res 2006;211:16-25.
21. Huang CQ, Tykocinski M, Stathopoulos D, Cowan R: Effects of steroids and lubricants on electrical impedance and tissue response following cochlear implantation. Cochlear Implants Int 2007;8:123-147.
22. James CJ, Fraysse B, Deguine O, Lenarz T, Mawman D, Ramos A, Ramsden R, Sterkers O: Combined electroacoustic stimulation in conventional candidates for cochlear implantation. Audiol Neurootol 2006;1(suppl 1):57-62.
23. Kiefer J, Gstoettner W, Baumgartner W, Pok SM, Tillein J, Ye Q, von Ilberg C: Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngol 2004;124:272-280.
24. Kiefer J, Pok M, Adunka O, Sturzebecher E, Baumgartner W, Schmidt M, Tillein J, Ye Q, Gstoettner W: Combined electric and acoustic stimulation of the auditory system: results of a clinical study. Audiol Neurootol 2005;10:134-144.
25. Lenarz T, Stover T, Buechner A, Paasche G, Briggs R, Risi F, Pesch J, Battmer RD: Temporal bone results and hearing preservation with a new straight electrode. Audiol Neurootol 2006;11(suppl 1):34-41.
26. Liu H, Chen X, Zhang S, Qu L, Zhao Y, Dong M: Separation and determination of dexamethasone sodium phosphate in cochlear perilymph fluid by liquid chromatography with ultraviolet monitoring and electrospray ionization mass spectrometry characterization. J Chromatogr B Analyt Technol Biomed Life Sci 2004;805:255-260.
27. Maeda K, Yoshida K, Ichimiya I, Suzuki M: Dexamethasone inhibits tumor necrosis factor-alpha-induced cytokine secretion from spiral ligament fibrocytes. Hear Res 2005;202:154-160.
28. Nadol JB Jr, Eddington DK: Histologic evaluation of the tissue seal and biologic response around cochlear implant electrodes in the human. Otol Neurotol 2004;25:257-262.
29. Noushi F, Richardson RT, Hardman J, Clark G, O'Leary S: Delivery of neurotrophin-3 to the cochlea using alginate beads. Otol Neurotol 2005;26:528-533.
30. Parnes LS, Sun AH, Freeman DJ: Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1-17.
31. Plontke SK, Zimmermann R, Zenner HP, Lowenheim H: Technical note on microcatheter implantation for local inner ear drug delivery: surgical technique and safety aspects. Otol Neurotol 2006;27:912-917.
32. Rybak LP, Whitworth CA: Ototoxicity: therapeutic opportunities. Drug Discov Today 2005;10:1313-1321.
33. Rybak LP, Whitworth CA, Mukherjea D, Ramkumar V: Mechanisms of cisplatin-induced ototoxicity and prevention. Hear Res 2007;226:157-167.
34. Salt AN, Hale SA, Plontke SK: Perilymph sampling from the cochlear apex: a reliable method to obtain higher purity perilymph samples from scala tympani. J Neurosci Methods 2006;153:121-129.
35. Sasson R, Amsterdam A: Pleiotropic anti-apoptotic activity of glucocorticoids in ovarian follicular cells. Biochem Pharmacol 2003;66:1393-1401.
36. Selivanova OA, Gouveris H, Victor A, Amedee RG, Mann W: Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss. Otol Neurotol 2005;26:890-895.
37. Shepherd RK, Clark GM: Progressive ototoxicity of neomycin monitored using derived brain-stem response audiometry. Hear Res 1985;18:105-110.
38. Silverstein H: Use of a new device, the Micro-Wick, to deliver medication to the inner ear. Ear Nose Throat J 1999;78:595-598, 600.
39. Takemura K, Komeda M, Yagi M, Himeno C, Izumikawa M, Doi T, Kuriyama H, Miller JM, Yamashita T: Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig. Hear Res 2004;196:58-68.
40. Tillein J: Hearing protection during cochlear implantation: experimental steroid delivery to the cochlea. Bionics and regeneration of the ear. 7th Int Acad Conf of Immunobiol in Otorhinolaryngol, Melbourne, 2006.
41. Trune DR, Kempton JB, Gross ND: Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hear Res 2006;212:22-32.
42. Xu SA, Shepherd RK, Chen Y, Clark GM: Profound hearing loss in the cat following the single co-administration of kanamycin and ethacrynic acid. Hear Res 1993;70:205-215.
43. Ye Q, Tillein J, Hartmann R, Gstoettner W, Kiefer J: Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention. Ear Hear 2007;28:361-369.